An Official Website of the United States Government
STTR Phase I: Nanoengineered Encapsulation of Therapeutics
- Small Business Information
-
Woman-Owned: NoMinority-Owned: YesHUBZone-Owned: No
- Phase 1
-
Fiscal Year: 2006Title: STTR Phase I: Nanoengineered Encapsulation of TherapeuticsAgency: NSFContract: 0610751Award Amount: $100,000.00
Abstract:
This Small Business Technology Transfer (STTR) Phase I project is a feasibility study for the design of true core-shell type nonocapsules for drug delivery. The research will focus on strategies aimed at controlling the nanostructure and chemistry of the capsules, and also on ways to design encapsulated therapeutics capable of being transported to specific parts of the body for targeted drug delivery. The capsule design strategy is rather general and the technology is expected to be portable to other therapeutic systems that may benefit from a similar delivery strategy. The research team expects to develop a commercial product line in the medium- and long-term, rather than a single encapsulated therapeutic. Market size is inferred from the number of patients per year the target encapsulated therapeutic is intended for. For the specific medical application, an upper limit of about l.5m patients per year in the US alone may benefit from new and improved drug delivery strategies.Small Business Information at Submission:Research Institution Information:LNKChemsolutions
2411 Winchester South Lincoln, NE 68512EIN/Tax ID:DUNS: N/ANumber of Employees:Woman-Owned: NoMinority-Owned: NoHUBZone-Owned: NoArgonne National Lab
9700 South Cass Avenue
Argonne, IL 60439Contact: Luis NunezContact Phone: (630) 252-8230RI Type: Domestic nonprofit research organization
Award Information
|
Agency: National Science Foundation |
Branch: N/A |
Award ID: 80190 |
Program Year/Program: 2006 / STTR |
|
Agency Tracking Number: 0610751 |
Solicitation Year: N/A |
Solicitation Topic Code: N/A |
Solicitation Number: N/A |